Tolcapone is worth a try when other treatments in patients with fluctuating Parkinson’s disease fail or are inappropriate Drug and Profile Reports 14 September 2012 Pages: 1 - 4
Although airbag deployment may induce injuries, the majority of these injuries are minor cutaneous lesions Disease Management 14 September 2012 Pages: 7 - 9
Community-acquired pneumonia (CAP) remains a serious threat to the elderly and should be treated empirically based on disease severity Disease Management 14 September 2012 Pages: 10 - 13
ACE inhibitors and calcium channel antagonists the safest bets for paediatric hypertension Disease Management 14 September 2012 Pages: 14 - 17
First reports of serious adverse drug reactions in recent weeks Drug Reactions and Interactions 14 September 2012 Pages: 18 - 18
Pharmacological agents can ameliorate some of the neuropsychiatric adverse effects of interferon-α treatment Drug Reactions and Interactions 14 September 2012 Pages: 18 - 22
Pharmacogenomics has promising applications in a number of areas of the drug discovery pipeline Practical Issues and Updates 14 September 2012 Pages: 24 - 26
